Missing/wrong data?
Log in to edit
A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination
Author/s
author: Antonia Pritchard, Anneliese O Speak, Francesco Iorio, Anton J. Enright, Ultan McDermott, Jyoti Choudhary, Julia A Newton Bishop, Theodoros I Roumeliotis, Daniel Peeper, Nicholas Hayward
Work details
Publication date
September 28, 2017
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.